Literature DB >> 3785295

Acute cardiac events temporally related to cocaine abuse.

J M Isner, N A Estes, P D Thompson, M R Costanzo-Nordin, R Subramanian, G Miller, G Katsas, K Sweeney, W Q Sturner.   

Abstract

The increasingly widespread use of cocaine in the United States has been accompanied and perhaps exacerbated by the misconception that the drug is not associated with serious medical complications. In particular, the potential for cocaine to precipitate life-threatening cardiac events needs to be reemphasized. We report the clinical and pathological findings in seven people in whom nonintravenous "recreational" use of cocaine was temporally related to acute myocardial infarction, ventricular tachycardia and fibrillation, myocarditis, sudden death, or a combination of these events. We also review data on 19 previously reported cases of cocaine-related cardiovascular disorders. Analysis of all 26 patients indicated the following findings: the cardiac consequences of cocaine abuse are not unique to parenteral use of the drug, since nearly all the patients took the drug intranasally; underlying heart disease is not a prerequisite for cocaine-related cardiac disorders; seizure activity, a well-documented noncardiac complication of cocaine abuse, is neither a prerequisite for, nor an accompanying feature of, cardiac toxicity of cocaine; and the cardiac consequences of cocaine are not limited to massive doses of the drug. Although the pathogenesis of cardiac toxicity of cocaine remains incompletely defined, available circumstantial evidence suggests that cocaine has medical consequences that are equal in importance to its well-documented psychosocial consequences.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3785295     DOI: 10.1056/NEJM198612043152302

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  65 in total

Review 1.  Recreational drug misuse: issues for the cardiologist.

Authors:  A Ghuran; J Nolan
Journal:  Heart       Date:  2000-06       Impact factor: 5.994

Review 2.  Myocardial infarction in patients with normal coronary arteries: proposed pathogenesis and predisposing risk factors.

Authors:  S P Pinney; L E Rabbani
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

3.  [Emergent surgery for body packing - what happens to the drugs?].

Authors:  M Wittau; D Weber; B Reher; K H Link; D Henne-Bruns; M Siech
Journal:  Chirurg       Date:  2004-04       Impact factor: 0.955

4.  Acute myocardial infarction associated with cocaine withdrawal.

Authors:  M A Levine; J Nishikawa
Journal:  CMAJ       Date:  1991-05-01       Impact factor: 8.262

Review 5.  Treatment of patients with cocaine-induced arrhythmias: bringing the bench to the bedside.

Authors:  Robert S Hoffman
Journal:  Br J Clin Pharmacol       Date:  2010-05       Impact factor: 4.335

Review 6.  Clinical toxicology of cocaine.

Authors:  K A Loper
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 May-Jun

7.  The effects of cocaine on intracellular Ca2+ handling and myofilament Ca2+ responsiveness of ferret ventricular myocardium.

Authors:  C L Perreault; N L Hague; B J Ransil; J P Morgan
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

8.  Successful treatment of cocaine-induced cardiotoxicity with carvedilol therapy.

Authors:  L Öcal; H Çakir; M Tellice; S İzci; E Alizade; A M Esen
Journal:  Herz       Date:  2013-11-01       Impact factor: 1.443

9.  Effects of intranasal cocaine on sympathetic nerve discharge in humans.

Authors:  T N Jacobsen; P A Grayburn; R W Snyder; J Hansen; B Chavoshan; C Landau; R A Lange; L D Hillis; R G Victor
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

10.  Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene.

Authors:  E F McCance-Katz; L H Price; C J McDougle; T R Kosten; J E Black; P I Jatlow
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.